The life science company Sartorius today acquired U.S.‑based purification expert WaterSep BioSeparations LLC through its subgroup Sartorius Stedim Biotech.
As gene therapies move towards commercialization, a robust, scalable and affordable manufacturing process is critical to ensure these novel therapies reach the patient and that a pipeline of clinical ...
In a new study published in the journal Developmental Cell, researchers at the Centre for Genomic Regulation (CRG) describe how human cells stimulate the production of microtubules, a fundamental b...
Aglaris Ltd, the innovator in cell therapy manufacturing, has been awarded three prestigious grants totalling over €2million to advance its breakthrough technologies towards commercialisation.
While the success of autologous chimeric antigen receptors (CAR) T-cell medicines cannot be denied, with the recent approvals of Kymriah (tisagenlecleucel) and Yescarta (axicabtagene ciloleucel) pavin...
